Our most recent news - February 2022

At the heart of IRCM's expertise

February 28, 2022 marks the 15th edition of International Rare Disease Awareness Day. As you know, the IRCM is home to some of the most hopeful research in this field.

A year-long Long COVID research clinic at IRCM

The IRCM is celebrating the first anniversary of its post-COVID-19 research clinic, whose valuable work is helping to elucidate the symptoms and lasting complications of the disease that plague the lives of a significant proportion of patients who have had COVID-19.

Women in science: new lights and old shadows

For the International Day of Women In Science that took place February 11, the IRCM saluted its excellent women researchers.

A prestigious nomination for Dr. André Veillette

Dr. André Veillette named first Executive Director of the Terry Fox Research Institute's Marathon of Hope Cancer Centers Network

CIHR grants: outstanding results for IRCM researchers

The IRCM proudly celebrates the success of its researchers with the awarding of six substantial grants from the CIHR for hopeful research at the IRCM.

Dr David Hipfner will lead the UdeM's molecular biology programs

This appointment also strengthens the strong ties that already exist between the Molecular Biology Department of the Université de Montréal and our Institute.

PCSK9 and its unsuspected roles in major pathologies: Twenty years of scientific adventure

The work of Dr. Nabil G. Seidah's team at the IRCM on the role of proprotein convertases has marked and continues to mark recent scientific history.

Dr. Paul Jolicoeur named Professor Emeritus of the IRCM

This outstanding scientist was recruited to the IRCM in 1976 by Dr. Jacques Genest and he directed the molecular biology research unit of the IRCM for nearly forty-five years.

A Canada Foundation for Innovation grant for two of our researchers

Researchers Tarik Möröy and Javier Marcelo Di Noia and their teams received a grant to support the equipment costs of their research in the fields of immunology and leukemia and lymphoma.

Launch of the Early-Career Scientists Seminar Series

This new program offers doctoral candidates and postdoctoral fellows from all over the world the opportunity to come and visit the IRCM to present their research to a multidisciplinary audience.

Basic and Clinical Oncology Seminar Series

These monthly seminars feature a clinical and a basic scientist speaker, both working on the same cancer in order to create a dialogue between those at the bench and their peers at the bedside.

The IRCM Conference Series

This conference series hosts internationally renowned specialists who discuss their work on various current medical research topics. Several conferences are scheduled in March. It's free and open to all.

EFFERVESCENCE 2022: a rich and varied program, with significant participation from IRCM

The industry's flagship event will indeed be back with a variety of inspiring and captivating talks on current topics relevant to our field.

Parcours santé Golf Tournament

The golf tournament of the IRCM Foundation will be back on June 20th. Have fun for a purpose and help raise funds in support of promising research conducted at the Institute.

In the Media

Quebecer with long COVID being studied at research institute calls for more support

She's among the 570 people with long COVID being studied at the IRCM post-COVID research clinic, since it opened its doors in February 2021.

Canada must address the global antiviral deficit

"In the rush to acquire vaccines, Canada overlooked the need to simultaneously create an antiviral development strategy." - Dr Michel Chrétien

Diabetes Canada Podcast

Dr. Jennifer Estall discusses her work looking at molecular changes in diabetes and how they might help in better understanding the condition and developing new therapies.

Vous recevez ce courriel parce que vous vous êtes abonnés à l'infolettre, vous faites partie de la communauté interne de l'IRCM, vous avez fait un don à la Fondation de l'IRCM ou vous avez participé à un événement organisé par l'IRCM.